The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used
Authors:
- P Marques-VidalP Marques-Vidal
- S VelhoSVS Velho
- D WaterworthDWD Waterworth
- G WaeberGWG Waeber
- R von KänelRKR von Känel
- P VollenweiderPVP Vollenweider
- 28 September 2011
- journal article
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 66 (4) , 426-435
Abstract
To assess the distribution of interleukin (IL)-1β, IL-6, tumour necrosis factor (TNF)-α and C-reactive protein (CRP) according to the different definitions of metabolically healthy obesity (MHO). A total of 881 obese (body mass index (BMI) > or =30 kg/m2) subjects derived from the population-based CoLaus Study participated in this study. MHO was defined using six sets of criteria including different combinations of waist, blood pressure, total high-density lipoprotein cholesterol or low-density lipoprotein -cholesterol, triglycerides, fasting glucose, homeostasis model, high-sensitivity CRP, and personal history of cardiovascular, respiratory or metabolic diseases. IL-1β, IL-6 and TNF-α were assessed by multiplexed flow cytometric assay. CRP was assessed by immunoassay. On bivariate analysis some, but not all, definitions of MHO led to significantly lower levels of IL-6, TNF-α and CRP compared with non-MH obese subjects. Most of these differences became nonsignificant after multivariate analysis. An posteriori analysis showed a statistical power between 9 and 79%, depending on the inflammatory biomarker and MHO definition considered. Further increasing sample size to overweight+obese individuals (BMI > or =25 kg/m2, n=2917) showed metabolically healthy status to be significantly associated with lower levels of CRP, while no association was found for IL-1β. Significantly lower IL-6 and TNF-α levels were also found with some but not all MHO definitions, the differences in IL-6 becoming nonsignificant after adjusting for abdominal obesity or percent body fat. MHO individuals present with decreased levels of CRP and, depending on MHO definition, also with decreased levels in IL-6 and TNF-α. Conversely, no association with IL-1β levels was found.Keywords
This publication has 39 references indexed in Scilit:
- Body Fat Distribution and Inflammation Among Obese Older Adults With and Without Metabolic SyndromeObesity, 2010
- Metabolically healthy obesity: different prevalences using different criteriaEuropean Journal of Clinical Nutrition, 2010
- Plasma Cytokine Levels in a Population-Based Study: Relation to Age and EthnicityThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2009
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic ReviewPLOS Medicine, 2008
- The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndromeBMC Cardiovascular Disorders, 2008
- Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO womenInternational Journal of Obesity, 2006
- Diverse Effect of Inflammatory Markers on Insulin Resistance and Insulin‐Resistance Syndrome in the ElderlyJournal of the American Geriatrics Society, 2004
- Body composition and energy metabolism in normotensive and hypertensive pregnancyBritish Journal of Obstetrics and Gynaecology, 2001
- Body water compartment measurements: A comparison of bioelectrical impedance analysis with tritium and sodium bromide dilution techniquesClinical Nutrition, 2001
- Body composition at the bedsideEuropean Journal of Gastroenterology & Hepatology, 1997